Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype

被引：0

作者：

Serafin, Andrea ^{[1
]}

Ruocco, Valeria ^{[1
]}

Cellini, Alessandro ^{[1
]}

Angotzi, Francesco ^{[1
]}

Bonaldi, Laura ^{[2
]}

Trentin, Livio ^{[1
]}

Visentin, Andrea ^{[1
]}

机构：

[1] Univ Padua, Dept Med DIMED, Hematol Unit, via Nicolo Giustiniani, 2, I-35128 Padua, Italy

[2] Veneto Inst Oncol, Immunol & Mol Oncol Unit, Padua, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 03期

关键词：

BTK inhibitors; chronic lymphocytic leukaemia; complex karyotype (CK); high-CK cytogenetic complexity; novel therapies; venetoclax; CHROMOSOMAL TRANSLOCATIONS; TELOMERE DYSFUNCTION; CLONAL EVOLUTION; TP53; MUTATIONS; CLL; RISK; TRANSFORMATION; IMPACT;

D O I：

10.1111/bjh.19986

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chronic lymphocytic leukaemia (CLL) is a heterogeneous disease characterised by the uncontrolled proliferation of mature lymphocytes. A subset of CLL patients harbouring complex karyotype (CK) presents with poor prognosis and limited treatment options. This review aims to discuss the current understanding of such patient subset, including its molecular landscape, diagnostic approaches, treatment modalities and emerging therapies. Furthermore, it outlines strategies for personalised management to improve clinical outcomes in this challenging patient population.

引用

页码：832 / 841

页数：10

共 50 条

[1] The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype
Strati, Paolo
Wang, Feng
Tambaro, Francesco P.
Thompson, Philip A.
Burger, Jan A.
Jain, Nitin
Ferrajoli, Alessandra
Bose, Prithviraj
Estrov, Zeev
Keating, Michael J.
Futreal, Andrew
Takahashi, Koichi
Wierda, William G.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : E1 - E4
[2] Complex karyotype in patients with chronic lymphocytic leukemia.
Yañez, L
Cuadrado, MA
Insunza, A
Mesones, BG
Bermudez, A
Conde, E
Bureo, E
Iriondo, A
BLOOD, 2005, 106 (11) : 328B - 328B
[3] Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens
Serafin, Andrea
Cellini, Alessandro
Cavarretta, Chiara Adele
Ruocco, Valeria
Angotzi, Francesco
Zatta, Ivan
Frezzato, Federica
Bonaldi, Laura
Martines, Annalisa
Pravato, Stefano
Piazza, Francesco
Trentin, Livio
Visentin, Andrea
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 189 - 193
[4] Management of Chronic Lymphocytic Leukaemia
Tse, E.
Gill, H. Singh
HONG KONG JOURNAL OF RADIOLOGY, 2011, 14 (04): : S56 - S62
[5] Management of chronic lymphocytic leukaemia
Kalil, N
Cheson, BD
DRUGS & AGING, 2000, 16 (01) : 9 - 27
[6] Management of Chronic Lymphocytic Leukaemia
Nelson Kalil
Bruce D. Cheson
Drugs & Aging, 2000, 16 : 9 - 27
[7] Coexistence of light chain disease and chronic lymphocytic leukaemia, a complex karyotype with a rapid fatal outcome
Castryck, H
Van den Driessche, M
Hagemeijer, A
Stul, M
Wynendaele, W
Vandenberghe, P
Moerman, J
CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (02): : 138 - 140
[8] The Landscape of Genetic Mutations in Patients with Chronic Lymphocytic Leukemia and Complex Karyotype
Strati, Paolo
Takahashi, Koichi
Wang, Feng
Tambaro, Francesco Paolo
Keating, Michael
Ferrajoli, Alessandra
Estrov, Zeev
Thompson, Phil
Jain, Nitin
Bose, Prithviraj
Futreal, Andrew
Wierda, William
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S212 - S213
[9] An update on the management of chronic lymphocytic leukaemia
Yee, KWL
O'Brien, SM
Giles, FJ
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (07) : 1535 - 1554
[10] Chronic lymphocytic leukaemia: Current management
Aurran-Schleinitz, T.
Arnoulet, C.
Ivanov, V.
Coso, D.
Rey, J.
Schiano, J. -M.
Stoppa, A. -M.
Bouabdallah, R.
Gastaut, J. -A.
REVUE DE MEDECINE INTERNE, 2008, 29 (05): : 424 - 435

← 1 2 3 4 5 →